Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Rossari Biotech IPO and Ujjivan Bank IPO.
Rossari Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Ujjivan Bank IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Rossari Biotech IPO | Ujjivan Bank IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Axis Bank Limited ICICI Securities Limited |
Iifl Securities Ltd Jm Financial Limited Kotak Mahindra Capital Company Limited |
| Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Rossari Biotech IPO is up to ₹496.49 Cr whereas the issue size of the Ujjivan Bank IPO is up to ₹750.00 Cr. The final issue price of Rossari Biotech IPO is ₹425.00 per share and of Ujjivan Bank IPO is ₹37.00 per share.
| Rossari Biotech IPO | Ujjivan Bank IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹423.00 per share | ₹36.00 per share |
| Issue Price (Upper) | ₹425.00 per share | ₹37.00 per share |
| Issue Price (Final) | ₹425.00 per share | ₹37.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 35 shares | 400 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | up to ₹50.00 Cr | |
| OFS Issue Size | 1,05,00,000 shares | |
| OFS Issue Size (Amount) | ||
| Issue Size Total | 1,16,82,033 shares | 20,83,33,333 shares |
| Issue Size Total (Amount) | up to ₹496.49 Cr | up to ₹750.00 Cr |
Rossari Biotech IPO opens on Jul 13, 2020, while Ujjivan Bank IPO opens on Dec 02, 2019. The closing date of Rossari Biotech IPO and Ujjivan Bank IPO is Jul 15, 2020, and Dec 04, 2019, respectively.
| Rossari Biotech IPO | Ujjivan Bank IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jul 13, 2020 | Dec 02, 2019 |
| Issue Close | Jul 15, 2020 | Dec 04, 2019 |
| Basis Of Allotment (Tentative) | Jul 20, 2020 | Dec 09, 2019 |
| Initiation of Refunds (Tentative) | Jul 21, 2020 | Dec 10, 2019 |
| Credit of Share (Tentative) | Jul 22, 2020 | Dec 11, 2019 |
| Listing date (Tentative) | Jul 23, 2020 | Dec 12, 2019 |
| Anchor Lockin End date 1 | Aug 19, 2020 | Jan 08, 2020 |
| Anchor Lockin End date 2 | Oct 18, 2020 | Mar 08, 2020 |
Rossari Biotech IPO P/E ratio is 33.81, as compared to Ujjivan Bank IPO P/E ratio of .
| Rossari Biotech IPO | Ujjivan Bank IPO | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 95.06% | 94.40% | |||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73% | 83.32% | |||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 33.81 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹2207.00 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | |||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | |||||||||||||||||||||||||||||||||||||||||||||||||
In the Rossari Biotech IPO retail investors (RII) are offered 40,86,765 shares while in Ujjivan Bank IPO retail investors are offered 40,86,765 shares. Qualified institutional buyers (QIB) are offered 23,35,294 shares in Rossari Biotech IPO and 5,62,50,000 shares in Ujjivan Bank IPO.
| Rossari Biotech IPO | Ujjivan Bank IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 23,35,294 shares | 5,62,50,000 shares |
| NII | 17,51,471 shares | 2,81,25,000 shares |
| RII | 40,86,765 shares | 1,87,50,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 81,73,530 shares | 12,39,58,333 shares |
Rossari Biotech IPO subscribed 79.37x in total, whereas Ujjivan Bank IPO subscribed 165.66x.
| Rossari Biotech IPO | Ujjivan Bank IPO | |
|---|---|---|
| QIB (times) | 85.26x | 110.72x |
| NII (times) | 239.83x | 473.00x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 7.23x | 48.97x |
| Employee (times) | ||
| Other (times) | 4.13x | |
| Total (times) | 79.37x | 165.66x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
